Clinical Trials in Nashville

Showing 4501-4520 of 20,298 trials

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

This study aims to evaluate the safety, tolerability, pharmacodynamic, and pharmacokinetic (PK) of nemtabrutinib (formerly ARQ 531) tablets in selected participants with relapsed or refractory hematologic malignancies. No formal hypothesis testing will be performed for this study.

Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)190 participantsStarted Jun 2017

Scottsdale, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +7 more locations

Active Not RecruitingPhase 3< 1 mile

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

NCT05444257

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated822 participantsStarted Nov 2022

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +192 more locations

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Find Trials by Condition in Nashville

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

Cholinergic Mechanisms of Attention in Aging

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

CREST-2 Long-term Observational Extension Study

Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

Expanded Access Program for Revumenib

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

International Rare Brain Tumor Registry

Hemorrhagic Myocardial Infarction Detection by Post-reperfusion Troponin Kinetics

Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy